GANX
Gain Therapeutics Inc
1.80$
+3.2%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Cash Flow
Gain Therapeutics Inc (GANX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -4.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.0 | -5.7 | -3.6 | -5.8 | -6.1 | -3.5 | -3.8 | -5.1 | -4.9 | -4.6 | -4.7 | -4.7 | -19 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.9 | 0.6 | 0.2 | 1.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | 1.8 | |
| 0.0 | -1.4 | 0.4 | 1.0 | -1.9 | -0.6 | 0.2 | -0.5 | -0.1 | -0.5 | 0.2 | -0.7 | -1.1 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 1.9 | 3.1 | 3.0 | 2.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | |
| 0.1 | 9.6 | -0.1 | 10 | 0.8 | 2.3 | 2.4 | 2.5 | 7.0 | 17 | 0.4 | 1.4 | 25 | |
| -2.0 | 7.5 | -1.2 | 6.3 | -4.9 | -1.7 | -1.3 | -2.4 | 2.1 | 12 | -4.3 | -3.5 | 6.4 | |
| -4.0 | -5.7 | -3.6 | -5.8 | -6.1 | -3.5 | -3.8 | -5.1 | -4.9 | -4.6 | -4.7 | -4.7 | -19 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.